Form 4: Perrigo Executive Charles Atkinson Granted Over 20,000 Restricted Stock Units
Insider Transaction Report
Perrigo Company plc's EVP, General Counsel & Secretary, Charles Atkinson, was granted 20,069 Restricted Stock Units, vesting over three years starting June 2026.
Summary
- Charles Atkinson, the Executive Vice President, General Counsel & Secretary of Perrigo Company plc (PRGO), was granted 20,069 Restricted Stock Units (RSUs).
- The transaction date for this equity grant was June 6, 2025.
- Each Restricted Stock Unit represents a contingent right to receive one ordinary share of Perrigo Company plc.
- These RSUs are scheduled to vest in three equal annual installments, with the first vesting date occurring on June 6, 2026.
- Following this reported transaction, Charles Atkinson directly beneficially owns 20,069 derivative securities in the form of Restricted Stock Units.
- The filing indicates that no non-derivative securities are beneficially owned by the reporting person.
Sentiment
Score: 7
Explanation: The grant of equity to a key executive is generally a positive indicator of executive retention and alignment of interests with shareholders. However, as a routine compensation disclosure, it does not significantly alter the company's fundamental outlook or financial performance.
Positives
- The grant of Restricted Stock Units aligns the executive's long-term financial interests with those of the company's shareholders, promoting sustained performance.
- The multi-year vesting schedule for the RSUs serves as an incentive for executive retention and continued commitment to the company's strategic objectives.
Negatives
- The executive does not receive immediate cash or fully vested shares from this grant, as the value is contingent on future share price performance and continued employment through vesting dates.
Risks
- The ultimate value realized from the Restricted Stock Units is directly tied to the future market price of Perrigo Company plc's ordinary shares, exposing the executive to market volatility.
- Vesting of the RSUs is typically contingent on the executive's continued employment with the company, meaning forfeiture could occur if employment ceases before the scheduled vesting dates.
Future Outlook
This filing primarily details an executive equity grant and does not contain forward-looking statements regarding the company's financial performance, strategic initiatives, or operational guidance.
Industry Context
Executive equity grants, such as Restricted Stock Units, are a standard component of compensation packages for senior management across various industries, including the consumer health and pharmaceutical sectors where Perrigo Company plc operates. These grants are designed to attract, retain, and motivate key executives by aligning their long-term financial interests with the company's performance and shareholder value creation.
Stakeholder Impact
- Shareholders: The RSU grant aligns the executive's incentives with shareholder value creation, as the value of the award is tied to the company's share price performance.
- Employees: This specific executive compensation event does not directly impact the broader employee base, but it reflects the company's overall executive compensation philosophy.
Next Steps
- The 20,069 Restricted Stock Units will vest in three equal annual installments, commencing on June 6, 2026.
Key Dates
| Date | Description |
|---|---|
| 06/06/2025 | Date of earliest transaction, specifically the grant of 20,069 Restricted Stock Units to Charles Atkinson. |
| 06/10/2025 | Date the Form 4 was signed by Victor Torres, attorney-in-fact for Charles Atkinson. |
| 06/06/2026 | First vesting date for the Restricted Stock Units, with subsequent vesting occurring in equal annual installments thereafter. |
Keywords
Perrigo, PRGO, Restricted Stock Units, RSU, Executive Compensation, Insider Transaction, Form 4, Equity Grant, Charles Atkinson
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.